Logo Rosalind & Morris Goodman Cancer Institute
Lastest news
thumbnail

The GCI Gazette Volume 1 Issue 1

We are thrilled to announce the launch of the first edition of the student-led GCI Gazette! Dive into our latest groundbreaking research, trainee spotlights, insightful op-eds, and fun games.

 

Download

The
knowledge
to cure

Rosalind & Morris Goodman Institute

We bring together some of the brightest minds in cancer research who uncover game-changing knowledge to help tackle cancer faster and more effectively.

Our researchers Our core facilities Our networks

video-image
The quest to overcome cancer

Our training programs

Our training programs

Eager to start your career in cancer research? Your journey starts here! By training at our Institute, you will be mentored by world leading researchers who are passionate about training the next generation of leaders.

Discover

A rewarding career awaits

A rewarding career awaits

Bring your passion and advance your career. Join our team driven by collaboration and a determination to make a difference for cancer patients.

Learn more

Events

thumbnail

GCI Frontiers in Cancer Research Lecture Series

Apr 07, 2025


"Force of nature: mechanical regulation of cancer plasticity" will be presented by Miranda V. Hunter, Ph.D, Postdoctoral Fellow, Memorial Sloan Kettering Cancer Center

 

thumbnail

GCI Frontiers in Cancer Research Lecture Series

Apr 23, 2025


"Passenger mutations that are backseat drivers in mouse models of breast cancer" will be presented by Eran Andrechek, PhD, Professor at Michigan State University.

 

thumbnail

GCI Frontiers in Cancer Research Lecture Series

May 02, 2025


"Next generation CRISPR tools to model and interrogate cancer" will be presented by Marco Herold, Chief Executive Officer, Olivia Newton-John Cancer Research Institute; Head, School of Cancer Medicine, La Trobe University; Laboratory Head, Blood Cancer and Immunotherapy Lab

 

thumbnail

GCI Frontiers in Cancer Research Lecture Series

May 07, 2025


"SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion" will be presented by Giuseppe Leuzzi, Principal Investigator | Functional Genomics of Cancer Immunity. IFOM, The AIRC Institute of Molecular Oncology, MIlan, Italy.

 

Finding knowledge that changes the outcome for cancer patients starts with you!

Groundbreaking research happens here every day. These great discoveries are not made by researchers alone. We rely on the support of our community to empower our scientists in bringing forward bold solutions to overcome cancer.

Make a difference today

Finding knowledge that changes the outcome for cancer patients starts with you!